722 related articles for article (PubMed ID: 36002043)
1. Type 1 diabetes and engineering enhanced islet transplantation.
Jeyagaran A; Lu CE; Zbinden A; Birkenfeld AL; Brucker SY; Layland SL
Adv Drug Deliv Rev; 2022 Oct; 189():114481. PubMed ID: 36002043
[TBL] [Abstract][Full Text] [Related]
2. Engineering Strategies to Improve Islet Transplantation for Type 1 Diabetes Therapy.
White AM; Shamul JG; Xu J; Stewart S; Bromberg JS; He X
ACS Biomater Sci Eng; 2020 May; 6(5):2543-2562. PubMed ID: 33299929
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Bioluminescence for the Detection of the Fate of Pancreatic Islet Organoids Post-transplantation.
Sun A; Kenyon E; Gudi M; Li W; Aguirre A; Wang P
Methods Mol Biol; 2023; 2592():195-206. PubMed ID: 36507995
[TBL] [Abstract][Full Text] [Related]
4. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
[TBL] [Abstract][Full Text] [Related]
5. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge.
Caldara R; Tomajer V; Monti P; Sordi V; Citro A; Chimienti R; Gremizzi C; Catarinella D; Tentori S; Paloschi V; Melzi R; Mercalli A; Nano R; Magistretti P; Partelli S; Piemonti L
Front Immunol; 2023; 14():1323439. PubMed ID: 38077372
[TBL] [Abstract][Full Text] [Related]
6. Enhancing longevity of immunoisolated pancreatic islet grafts by modifying both the intracapsular and extracapsular environment.
Qin T; Smink AM; de Vos P
Acta Biomater; 2023 Sep; 167():38-53. PubMed ID: 37392934
[TBL] [Abstract][Full Text] [Related]
7. Islet Transplantation to the Anterior Chamber of the Eye-A Future Treatment Option for Insulin-Deficient Type-2 Diabetics? A Case Report from a Nonhuman Type-2 Diabetic Primate.
Tun SBB; Chua M; Hasan R; Köhler M; Zheng X; Ali Y; Abdulreda MH; Juntti-Berggren L; Barathi VA; Berggren PO
Cell Transplant; 2020; 29():963689720913256. PubMed ID: 32264703
[TBL] [Abstract][Full Text] [Related]
8. Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?
Potter KJ; Westwell-Roper CY; Klimek-Abercrombie AM; Warnock GL; Verchere CB
Diabetes; 2014 Jan; 63(1):12-9. PubMed ID: 24357689
[TBL] [Abstract][Full Text] [Related]
9. Cell Therapy for Type 1 Diabetes: From Islet Transplantation to Stem Cells.
Sordi V; Monaco L; Piemonti L
Horm Res Paediatr; 2023; 96(6):658-669. PubMed ID: 36041412
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of stem cells into insulin-producing cells: current status and challenges.
Pokrywczynska M; Krzyzanowska S; Jundzill A; Adamowicz J; Drewa T
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):149-58. PubMed ID: 23283518
[TBL] [Abstract][Full Text] [Related]
11. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
Triolo TM; Bellin MD
Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
[TBL] [Abstract][Full Text] [Related]
12. How to make insulin-producing pancreatic β cells for diabetes treatment.
Lu J; Xia Q; Zhou Q
Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
[TBL] [Abstract][Full Text] [Related]
13. Engineering β Cell Replacement Therapies for Type 1 Diabetes: Biomaterial Advances and Considerations for Macroscale Constructs.
Quizon MJ; García AJ
Annu Rev Pathol; 2022 Jan; 17():485-513. PubMed ID: 34813353
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation.
Korutla L; Rickels MR; Hu RW; Freas A; Reddy S; Habertheuer A; Harmon J; Korutla V; Ram C; Naji A; Vallabhajosyula P
Am J Transplant; 2019 Jun; 19(6):1852-1858. PubMed ID: 30801971
[TBL] [Abstract][Full Text] [Related]
15. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
[TBL] [Abstract][Full Text] [Related]
16. Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.
Wang X; Brown NK; Wang B; Shariati K; Wang K; Fuchs S; Melero-Martin JM; Ma M
Adv Sci (Weinh); 2021 Sep; 8(17):e2003708. PubMed ID: 34258870
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the design of implantable insulin secreting heterocellular islet organoids.
Akolpoglu MB; Inceoglu Y; Bozuyuk U; Sousa AR; Oliveira MB; Mano JF; Kizilel S
Biomaterials; 2021 Feb; 269():120627. PubMed ID: 33401104
[TBL] [Abstract][Full Text] [Related]
18. From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes.
Azad A; Altunbas HA; Manguoglu AE
Expert Rev Endocrinol Metab; 2024 May; 19(3):217-227. PubMed ID: 38693782
[TBL] [Abstract][Full Text] [Related]
19. The Current Status of Allogenic Islet Cell Transplantation.
Czarnecka Z; Dadheech N; Razavy H; Pawlick R; Shapiro AMJ
Cells; 2023 Oct; 12(20):. PubMed ID: 37887267
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells as feeder cells for pancreatic islet transplants.
Sordi V; Piemonti L
Rev Diabet Stud; 2010; 7(2):132-43. PubMed ID: 21060972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
